Viewing StudyNCT00256711



Ignite Creation Date: 2024-05-05 @ 12:08 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00256711
Status: COMPLETED
Last Update Posted: 2009-04-23
First Post: 2005-11-20

Brief Title: Phase II Iressa Versus Vinorelbine INVITE
Sponsor: AstraZeneca
Organization: AstraZeneca

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-07
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2006-02
Completion Date Type: ACTUAL
First Submit Date: 2005-11-20
First Submit QC Date: November 20 2005
Study First Post Date: 2005-11-22
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2009-04-22
Last Update Post Date: 2009-04-23
Last Update Post Date Type: ESTIMATED